Coeptis Therapeutics President and CEO Issues Letter to Shar

WEXFORD, Pa., Jan. 4, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. , a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced that Dave...

Related Keywords

, Dave Mehalick , Daniel Kontoh Boateng , Colleen Delaney , Karolinska Institutet , David Schemelia , Securities Exchange , Exchange Commission , Karolinska Institute , Coeptis Therapeutics Holdings Inc , Company Or Coeptis , Deverra Therapeutics Inc , Prnewswire Coeptis Therapeutics Holdings Inc , Holdings Inc , Drug Administration , Coeptis Therapeutics Holdings , Nasdaq , University Of Pittsburgh , Coeptis Therapeutics Inc , Tiberend Strategic Advisors Inc , Coeptis Pharmaceuticals Inc , Therapeutics Holdings , Deverra Therapeutics , Chief Scientific , Rapidly Advancing Clinical Programs , Emerging Leader , Natural Killer Cell , Gene Meeting , Coeptis Therapeutics , Coeptis Pharmaceuticals , Securities Act , Securities Exchange Act , Nasdaq Capital Market , Strategic Advisors , Markets ,